IOL CHEMICALS & PHARM. | AARTI PHARMALABS | IOL CHEMICALS & PHARM./ AARTI PHARMALABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 24.3 | 56.2% | View Chart |
P/BV | x | 1.6 | 3.0 | 51.2% | View Chart |
Dividend Yield | % | 1.0 | 0.4 | 261.3% |
IOL CHEMICALS & PHARM. AARTI PHARMALABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
AARTI PHARMALABS Mar-23 |
IOL CHEMICALS & PHARM./ AARTI PHARMALABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 397 | 135.2% | |
Low | Rs | 272 | 269 | 101.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 214.6 | 175.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | 21.3 | 111.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 28.3 | 111.7% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.0 | 0.6 | 164.7% | |
Book value per share (Unadj.) | Rs | 256.8 | 172.0 | 149.3% | |
Shares outstanding (eoy) | m | 58.71 | 90.63 | 64.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.6 | 69.0% | |
Avg P/E ratio | x | 17.1 | 15.6 | 109.4% | |
P/CF ratio (eoy) | x | 12.8 | 11.8 | 108.7% | |
Price / Book Value ratio | x | 1.6 | 1.9 | 81.3% | |
Dividend payout | % | 16.9 | 9.4 | 180.2% | |
Avg Mkt Cap | Rs m | 23,743 | 30,178 | 78.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,297 | 129.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 19,452 | 114.0% | |
Other income | Rs m | 256 | 23 | 1,104.8% | |
Total revenues | Rs m | 22,427 | 19,476 | 115.2% | |
Gross profit | Rs m | 2,257 | 3,421 | 66.0% | |
Depreciation | Rs m | 462 | 625 | 73.8% | |
Interest | Rs m | 165 | 211 | 78.2% | |
Profit before tax | Rs m | 1,887 | 2,608 | 72.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 673 | 73.6% | |
Profit after tax | Rs m | 1,391 | 1,935 | 71.9% | |
Gross profit margin | % | 10.2 | 17.6 | 57.9% | |
Effective tax rate | % | 26.2 | 25.8 | 101.7% | |
Net profit margin | % | 6.3 | 9.9 | 63.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,558 | 83.6% | |
Current liabilities | Rs m | 5,025 | 5,916 | 84.9% | |
Net working cap to sales | % | 20.9 | 29.0 | 72.2% | |
Current ratio | x | 1.9 | 2.0 | 98.5% | |
Inventory Days | Days | 43 | 16 | 269.3% | |
Debtors Days | Days | 8 | 826 | 1.0% | |
Net fixed assets | Rs m | 11,017 | 10,752 | 102.5% | |
Share capital | Rs m | 587 | 453 | 129.6% | |
"Free" reserves | Rs m | 14,490 | 15,132 | 95.8% | |
Net worth | Rs m | 15,077 | 15,585 | 96.7% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 20,684 | 22,309 | 92.7% | |
Interest coverage | x | 12.5 | 13.4 | 93.0% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.9 | 122.9% | |
Return on assets | % | 7.5 | 9.6 | 78.2% | |
Return on equity | % | 9.2 | 12.4 | 74.3% | |
Return on capital | % | 13.6 | 18.1 | 75.2% | |
Exports to sales | % | 26.7 | 32.0 | 83.5% | |
Imports to sales | % | 0 | 10.1 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 6,231 | 95.2% | |
Imports (cif) | Rs m | NA | 1,959 | 0.0% | |
Fx inflow | Rs m | 5,930 | 6,231 | 95.2% | |
Fx outflow | Rs m | 6,052 | 2,061 | 293.7% | |
Net fx | Rs m | -122 | 4,171 | -2.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,630 | 46.5% | |
From Investments | Rs m | -1,200 | -1,578 | 76.0% | |
From Financial Activity | Rs m | -41 | -1,635 | 2.5% | |
Net Cashflow | Rs m | -18 | -583 | 3.2% |
Indian Promoters | % | 48.2 | 46.3 | 104.1% | |
Foreign collaborators | % | 0.0 | 0.2 | - | |
Indian inst/Mut Fund | % | 1.7 | 18.3 | 9.3% | |
FIIs | % | 1.4 | 8.3 | 16.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 53.5 | 96.8% | |
Shareholders | 130,003 | 204,122 | 63.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | AARTI PHARMALABS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | -1.51% | 0.45% |
1-Month | 5.76% | 17.34% | 2.55% |
1-Year | -2.63% | 44.12% | 56.14% |
3-Year CAGR | -12.88% | 11.44% | 15.22% |
5-Year CAGR | 16.82% | 6.72% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the AARTI PHARMALABS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of AARTI PHARMALABS the stake stands at 46.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of AARTI PHARMALABS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
AARTI PHARMALABS paid Rs 2.0, and its dividend payout ratio stood at 9.4%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of AARTI PHARMALABS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.